Furthermore, in a subset of ovarian cancer cells that display an NRG1-expressing/phosphorylated-ErbB3 phenotype, depletion of ErbB3 by RNA interference (RNAi) could result in anti-proliferative effects in vitro. This evidence concerns the gene ERBB3 and ovarian carcinoma.